Ignite Creation Date:
2025-12-24 @ 9:10 PM
Ignite Modification Date:
2026-01-13 @ 7:55 AM
Study NCT ID:
NCT05925504
Status:
RECRUITING
Last Update Posted:
2024-03-12
First Post:
2023-06-21
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
The Tapering Dose of Luspatercept in Patients With Lower-risk Myelodysplastic Syndromes
Sponsor:
Institute of Hematology & Blood Diseases Hospital, China
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
Lusp-MDS
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | UNKNOWN | View |